Faeth Therapeutics

FTH
Categories
Founded

2022

Leadership
  • Anand Parikh, JD, Co-Founder and CEO
Headquarters

San Francisco, CA

Website

faeththerapeutics.com

S2G North Star Interim Outcomes Jump to footnote 1
  • Increased availability, accessibility, and/or affordability of healthier foods and nutrition-based solutions
UN SDG Alignment Jump to footnote 2
  • Good Health and Well-Being
Faeth Therapeutics is a clinical-stage biotechnology company focused on improving outcomes for cancer patients.

The company’s lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Insights

News

Footnotes

  1. S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.

  2. UN Sustainable Development Goal (SDG) alignment has been obtained from portfolio companies, internally collected data by S2G and/​or sources outside S2G, and could prove to be incomplete or inaccurate and is current only as of July 31, 2026. S2G makes no representations as to the accuracy or completeness of the information obtained from such portfolio companies and/​or sources and neither S2G nor any of its affiliates takes any responsibility for, and has not independently verified, any such information.